• World News
  • Investing
  • Economy
  • Politics
  • Editor’s Pick
Target Line News
Politics

Bipartisan senators’ bill would require Congress to approve new tariffs

by April 4, 2025
by April 4, 2025

Two senior lawmakers have introduced a bipartisan bill that would reassert Congress’ powers over U.S. tariffs, a day after President Donald Trump announced a new wide-ranging tariff strategy during his ‘Liberation Day’ speech on Wednesday.

Sens. Chuck Grassley, R-Iowa, and Maria Cantwell, D-Wash., on Thursday introduced the Trade Review Act of 2025, which would require the president to notify Congress about any new tariffs within 48 hours of imposition. 

The bill also requires that Trump provide an explanation of the rationale along with an analysis of the tariffs’ potential impact on the U.S. economy. Congress would have to approve the new tariffs within 60 days or allow them to expire.

If enacted, the bill would shift certain trade policymaking powers from the executive branch to the Congress. 

‘For too long, Congress has delegated its clear authority to regulate interstate and foreign commerce to the executive branch,’ Grassley, a Trump ally who is skeptical of tariffs, said in a statement. 

‘Building on my previous efforts as Finance Committee Chairman, I’m joining Senator Cantwell to introduce the bipartisan Trade Review Act of 2025 to reassert Congress’ constitutional role and ensure Congress has a voice in trade policy,’ he continued.

Cantwell said in a statement that Trump’s tariffs would hurt sectors such as agriculture, manufacturing and technology and have reverberating effects on consumers.

‘Ultimately, consumers will pay the price,’ Cantwell said in a statement. ‘It’s time for Congress to take action to counter the president’s trade war.’

Grassley’s home state of Iowa heavily relies on farm crop exports, while Cantwell’s Washington state is home to many export-heavy companies such as Boeing.

Trump on Thursday compared the tariffs to a medical operation, and said the ‘patient lived, and is healing.’ ‘The prognosis is that the patient will be far stronger, bigger, better, and more resilient than ever before,’ he wrote on Truth Social.

Thursday’s bill was introduced after four Republican senators joined Democrats in approving a separate resolution on Wednesday that would repeal Trump’s emergency declaration levying tariffs on Canadian imports. Grassley was not one of the Republican defectors. The resolution is likely dead on arrival in the House.

This post appeared first on FOX NEWS

0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump urged to review UN immunity, lax visa rules amid national security concerns
next post
Trump publicly backs France’s far-right figurehead Le Pen after her conviction

You may also like

Trump’s MAGA imprint on GOP strong now, but...

April 27, 2025

Trump delivers different message on Gaza when recapping...

April 27, 2025

Alex Soros in hot seat after left-wing outlet...

April 27, 2025

Experts reveal Trump’s next move could be ‘nail...

April 27, 2025

Here’s what happened during Trump’s 14th week in...

April 27, 2025

Trump’s ‘STOP’ message to Putin echoes Biden’s ‘don’t’...

April 26, 2025

Trump’s goodwill tested as Putin ignores peace efforts...

April 26, 2025

Trump says he wasn’t ‘trolling’ about acquiring Greenland,...

April 26, 2025

Hegseth signs ‘No More Walking on Eggshells’ policy,...

April 26, 2025

Judge temporarily blocks Trump order ending collective bargaining...

April 26, 2025







    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: targetlinenews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 targetlinenews.com | All Rights Reserved

    Target Line News
    • World News
    • Investing
    • Economy
    • Politics
    • Editor’s Pick